QIAGEN Gains FDA Clearance for QIAstat-Dx Bloodstream Panel
GERMANTOWN, Md. and VENLO, Netherlands — September 28, 2026 QIAGEN N.V. announced that the U.S. Food and Drug Administration...
Gram-Negative Bacteria
Advertisement
Shionogi Expands Fetroja Role in U.S. Drug-Resistance Preparedness
Osaka, Japan – August 28, 2026 Shionogi & Co., Ltd. announced that the Biomedical Advanced Research and Development Authority...
Blacksmith Medicines Advances Novel Antibiotic Discovery
San Diego, California, USA, August 8, 2026 Blacksmith Medicines has announced the publication of new research in the Journal...
FDA Accepts Shionogi’s sNDA for Fetroja in Pediatric Gram-Negative Infections
FLORHAM PARK, N.J., July 16, 2026 Shionogi Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted...
Advertisement
